Thomas P. Blackburn

Person

Hoboken, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Indolone compounds useful to treat cognitive impairment
- Patent number 7,642,281
- Issue date Jan 5, 2010
- Helicon Therapeutics, Inc.
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of GAL3 antagonist for treatment of depression and/or anxiety a...
- Patent number 7,465,750
- Issue date Dec 16, 2008
- H. Lundbeck A/S
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compound useful for the treatment of neuropathic pain
- Patent number 7,220,775
- Issue date May 22, 2007
- H. Lundbeck A/S
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INDOLONE COMPOUNDS USEFUL TO TREAT COGNITIVE IMPAIRMENT
- Publication number 20100179187
- Publication date Jul 15, 2010
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of GAL3 receptor antagonists for the treatment of depression an...
- Publication number 20090318504
- Publication date Dec 24, 2009
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of Modulating Neurite Outgrowth by the use of a Galanin-3 Re...
- Publication number 20080039496
- Publication date Feb 14, 2008
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of GAL3 antagonist for treatment of depression and/or anxiety a...
- Publication number 20070259942
- Publication date Nov 8, 2007
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Indolone Compounds Useful To Treat Cognitive Impairment
- Publication number 20070135510
- Publication date Jun 14, 2007
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Indolone compounds useful to treat cognitive impairment
- Publication number 20070135509
- Publication date Jun 14, 2007
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of GAL3 antagonist for treatment of depression
- Publication number 20040127502
- Publication date Jul 1, 2004
- Synaptic Pharmaceutical Corporation
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GAL3 receptor antagonists for the treatment of affective disorders
- Publication number 20040110821
- Publication date Jun 10, 2004
- Michael J. Konkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GAL3 antagonists for the treatment of neuropathic pain
- Publication number 20040092570
- Publication date May 13, 2004
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DNA encoding a human melanin concentrating hormone receptor (MCH1)...
- Publication number 20030082623
- Publication date May 1, 2003
- Beth Borowsky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of GAL3 receptor antagonists for the treatment of depression an...
- Publication number 20030078271
- Publication date Apr 24, 2003
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Thomas P. Blackburn

Person

Patents Grantslast 30 patents

Indolone compounds useful to treat cognitive impairment

Use of GAL3 antagonist for treatment of depression and/or anxiety a...

Compound useful for the treatment of neuropathic pain

Patents Applicationslast 30 patents

INDOLONE COMPOUNDS USEFUL TO TREAT COGNITIVE IMPAIRMENT

Use of GAL3 receptor antagonists for the treatment of depression an...

Method of Modulating Neurite Outgrowth by the use of a Galanin-3 Re...

Use of GAL3 antagonist for treatment of depression and/or anxiety a...

Indolone Compounds Useful To Treat Cognitive Impairment

Indolone compounds useful to treat cognitive impairment

Use of GAL3 antagonist for treatment of depression

GAL3 receptor antagonists for the treatment of affective disorders

GAL3 antagonists for the treatment of neuropathic pain

DNA encoding a human melanin concentrating hormone receptor (MCH1)...

Use of GAL3 receptor antagonists for the treatment of depression an...